These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 2818677

  • 1. Antiestrogenic and antitumor effects of droloxifene in experimental breast carcinoma.
    Kawamura I, Mizota T, Mukumoto S, Manda T, Masuda K, Nakamura T, Kubota H, Matsumoto S, Nishigaki F, Shimomura K.
    Arzneimittelforschung; 1989 Aug; 39(8):889-93. PubMed ID: 2818677
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS, Parker CJ, McCague R, Jordan VC.
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells.
    Kawamura I, Lacey E, Mizota T, Tsujimoto S, Nishigaki F, Manda T, Shimomura K.
    Anticancer Res; 1994 Mar; 14(2A):427-31. PubMed ID: 8017842
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The estrogenic and antiestrogenic activities of droloxifene in human breast cancers.
    Kawamura I, Mizota T, Lacey E, Tanaka Y, Manda T, Shimomura K, Kohsaka M.
    Jpn J Pharmacol; 1993 Sep; 63(1):27-34. PubMed ID: 8271528
    [Abstract] [Full Text] [Related]

  • 7. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC, O'Regan RM, Gajdos C, Robinson SP, Bentrem D, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological activities of droloxifene isomers.
    Löser R, Seibel K, Huber HJ.
    Anticancer Res; 1988 Jun; 8(6):1271-4. PubMed ID: 3218958
    [Abstract] [Full Text] [Related]

  • 9. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X, Pisha E, Tonetti DA, Yao D, Li Y, Yao J, Burdette JE, Bolton JL.
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [Abstract] [Full Text] [Related]

  • 10. Preclinical data for Droloxifene.
    Hasmann M, Rattel B, Löser R.
    Cancer Lett; 1994 Sep 15; 84(2):101-16. PubMed ID: 8076367
    [Abstract] [Full Text] [Related]

  • 11. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Exp Biol Med (Maywood); 2007 Sep 15; 232(8):1071-80. PubMed ID: 17720953
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor effects of droloxifene, a new antiestrogen drug, against 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Kawamura I, Mizota T, Kondo N, Shimomura K, Kohsaka M.
    Jpn J Pharmacol; 1991 Oct 15; 57(2):215-24. PubMed ID: 1812300
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K, Lee ES, Bentrem DJ, England G, Schafer JI, O'Regan RM, Jordan VC.
    Clin Cancer Res; 2000 May 15; 6(5):2028-36. PubMed ID: 10815929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.